Nikitenko N.A.
Количество цитирований статей в журналах по данным
Web of Science: 475,
Scopus: 509
IstinaResearcherID (IRID): 7127806
Деятельность
-
Статьи в журналах
-
-
2021
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
-
Logunov Denis Y.,
Dolzhikova Inna V.,
Shcheblyakov Dmitry V.,
Tukhvatulin Amir I.,
Zubkova Olga V.,
Dzharullaeva Alina S.,
Kovyrshina Anna V.,
Lubenets Nadezhda L.,
Grousova Daria M.,
Erokhova Alina S.,
Botikov Andrei G.,
Izhaeva Fatima M.,
Popova Olga,
Ozharovskaya Tatiana A.,
Esmagambetov Ilias B.,
Favorskaya Irina A.,
Zrelkin Denis I.,
Voronina Daria V.,
Shcherbinin Dmitry N.,
Semikhin Alexander S.,
Simakova Yana V.,
Tokarskaya Elizaveta A.,
Egorova Daria A.,
Shmarov Maksim M.,
Nikitenko Natalia A.,
Gushchin Vladimir A.,
Smolyarchuk Elena A.,
Zyryanov Sergey K.,
Borisevich Sergei V.,
Naroditsky Boris S.,
Gintsburg Alexander L.
-
в журнале The Lancet, издательство The Lancet Publishing Group (United Kingdom)
DOI
-
-
2020
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
-
Logunov DY,
Dolzhikova IV,
Zubkova OV,
Tukhvatullin AI,
Shcheblyakov DV,
Dzharullaeva AS,
Grousova DM,
Erokhova AS,
Kovyrshina AV,
Botikov AG,
Izhaeva FM,
Popova O.,
Ozharovskaya TA,
Esmagambetov IB,
Favorskaya IA,
Zrelkin DI,
Voronina DV,
Shcherbinin DN,
Semikhin AS,
Simakova YV,
Tokarskaya EA,
Lubenets NL,
Egorova DA,
Shmarov MM,
Nikitenko NA,
Morozova LF,
Smolyarchuk EA,
Kryukov EV,
Babira VF,
Borisevich SV,
Naroditsky BS,
Gintsburg AL
-
в журнале The Lancet, издательство The Lancet Publishing Group (United Kingdom), том 396, № 10255, с. 887-897
DOI
-
-
2015
Regulation of Human Adenovirus Replication by RNA Interference
-
Nikitenko N.A.,
Speiseder T.,
Lam E.,
Rubtsov P.M.,
Tonaeva Kh D.,
Borzenok S.A.,
Dobner T.,
Prassolov V.S.
-
в журнале Acta Naturae (англоязычная версия), издательство Park Media Ltd (Moscow, Russia (Federation)), том 7, № 3, с. 100-107
-
-
2014
Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling
-
Spirin P.V.,
Lebedev T.D.,
Orlova N.N.,
Gornostaeva A.S.,
Prokofjeva M.M.,
Nikitenko N.A.,
Dmitriev S.E.,
Buzdin A.A.,
Borisov N.M.,
Aliper A.M.,
Garazha A.V.,
Rubtsov P.M.,
Stocking C.,
Prassolov V.S.
-
в журнале Leukemia, издательство Nature Publishing Group (United Kingdom), том 28, № 11, с. 2222-2228
DOI
-
-
Доклады на конференциях
-
-
2015
Suppression of RUNX1-RUNX1T1 gene expression leads to activation of both survival and proliferation signaling in acute myeloid leukemia cells
(Устный)
-
Авторы:
Spirin P.,
Lebedev T.,
Orlova N.,
Prokofjeva M.,
Prassolov V.,
Dmitriev S.,
Buzdin A.,
Rubtsov P.,
Stocking C.,
Nikitenko N.
-
The 40th FEBS Congress, Берлин, Германия, 4-9 июля 2015
-
Тезисы докладов
-
-
1997
Influence of Ascolong-novel form of Acetylsalycilic acid on hemostatic parameters in patients with ischemic heart and cerebrovascular diseases
-
Maksimova M.Yu,
Metelica V.,
Suslina Z.,
Kokurina E.,
Ionova V.,
Nikitenko N.
-
в сборнике Thrombosis and Haemostasis. – Suppl., Abstr. of XYI Congress of the International Thrombosis and Haemostasis, Florency, Italy, тезисы, с. 80-81
-